World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
14226
World Ranking
2258
National Ranking
27

Overview

Filip De Keyser is affiliated with Ghent University Hospital in Belgium and specializes in medical research, particularly within the field of Medicine. Their work spans several subfields including Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Rheumatology, Dermatology, and Genetics.

The main research topics covered by Filip De Keyser include:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chronic Lymphocytic Leukemia Research
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis

Filip De Keyser has contributed to a number of scientific publications, including the following notable papers:

  • "Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy" (2020), Clinical and Experimental Rheumatology
  • "Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study" (2021), Seminars in Arthritis and Rheumatism
  • "Prevalence and management of drug interactions between nonsteroidal anti-inflammatory drugs and antithrombotics in ambulatory care" (2022), British Journal of Clinical Pharmacology
  • "Flemish network on rare connective tissue diseases (CTD): patient pathways in systemic sclerosis. First steps taken" (2023), Acta Clinica Belgica
  • "Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases" (2020), Rheumatology and Therapy

Frequent co-authors working alongside Filip De Keyser include:

  • Yves Piette
  • Vanessa Smith
  • Daniël Blockmans
  • Wim Wuyts
  • Ellen De Langhe

Their research has been published multiple times in venues such as:

  • Clinical and Experimental Rheumatology
  • Seminars in Arthritis and Rheumatism
  • British Journal of Clinical Pharmacology
  • Acta Clinica Belgica
  • Rheumatology and Therapy

Best Publications

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

    Filip Van den Bosch;Elli Kruithof;Dominique Baeten;Annemie Herssens

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • The C-terminal RG Dipeptide Repeats of the Spliceosomal Sm Proteins D1 and D3 Contain Symmetrical Dimethylarginines, Which Form a Major B-cell Epitope for Anti-Sm Autoantibodies

    Hero Brahms;Jos Raymackers;Ann Union;Filip de Keyser

  • Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

    F Van den Bosch;E Kruithof;D Baeten;F De Keyser

  • Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

    Elli Kruithof;Dominique Lp Baeten;Leen De Rycke;Bernard Vandooren

  • Ankylosing spondylitis and bowel disease

    Dominique Baeten;Filip De Keyser;Herman Mielants;Eric M Veys

  • Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy

    Leen De Rycke;Elli Kruithof;Nancy Van Damme;Ilse E. A. Hoffman

  • Crohn's disease associated with spondyloarthropathy : effect of TNF-α blockade with infliximab on articular symptoms

    Filip Van den Bosch;Elli Kruithof;Martine De Vos;Filip De Keyser

  • Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study.

    Dominique Baeten;Dominique Baeten;Elli Kruithof;Filip Van den Bosch;Pieter Demetter

  • Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.

    Fotini B. Karassa;Antonella Afeltra;Ales Ambrozic;Deh-Ming Chang

  • Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: Relevance to antifilaggrin autoantibodies

    Dominique Baeten;Isabelle Peene;Ann Union;Lydie Meheus

  • Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

    Dominique Baeten;Pieter Demetter;Claude A. Cuvelier;Elli Kruithof

  • Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

    Olga Gorlova;Jose Ezequiel Martin;Blanca Rueda;Bobby P C Koeleman

  • Vaccinations in patients with immune-mediated inflammatory diseases

    Jean-François Rahier;Michel Moutschen;Alfons Van Gompel;Marc Van Ranst

  • The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis.

    Stefan Bläß;Ann Union;Jos Raymackers;Frank Schumann

  • Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.

    Leen de Rycke;Dominique Baeten;Elli Kruithof;Filip Van den Bosch

  • Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis

    Lode Melis;Bernard Vandooren;Elli Kruithof;Peggy Jacques

  • Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy

    Dominique Lp Baeten;Elli Kruithof;Leen De Rycke;Anemieke M Boots

  • Fibrin Deimination in Synovial Tissue Is Not Specific for Rheumatoid Arthritis but Commonly Occurs during Synovitides

    Sabine Chapuy-Regaud;Mireille Sebbag;Dominique Baeten;Cyril Clavel

  • Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis–specific humoral autoimmunity

    Leen De Rycke;Anthony P. Nicholas;Tineke Cantaert;Elli Kruithof

Frequent Co-Authors

Eric Veys
Eric Veys Ghent University Hospital
Herman Mielants
Herman Mielants Ghent University Hospital
Dirk Elewaut
Dirk Elewaut Ghent University
Dominique Baeten
Dominique Baeten University of Amsterdam
Maurizio Cutolo
Maurizio Cutolo University of Genoa
Guy Brusselle
Guy Brusselle Ghent University Hospital
Dieter Deforce
Dieter Deforce Ghent University
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Johannes Roth
Johannes Roth University of Münster
Valeria Riccieri
Valeria Riccieri Sapienza University of Rome

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA often pairs well with nursing and healthcare-related degrees, offering diverse career opportunities. For those interested in advancing their clinical expertise, transitioning through an fnp to acute care certification can open doors to specialized patient care roles in acute settings.

Accelerated nursing programs are also popular among students aiming to fast-track their qualifications. Enrolling in an accelerated fnp program can significantly reduce the time needed to become a Family Nurse Practitioner, blending well with immunology knowledge for managing immune-related diseases.

For those starting fresh without a nursing background, online bsn programs for non nurses offer flexible pathways to enter the nursing field, complementing immunology studies. These programs cater to career changers seeking to build foundational skills efficiently.

Additionally, finding the right program fit is crucial. Considering the easiest absn program to get into may help prospective students gain quicker access to nursing education and jumpstart their healthcare careers aligned with immunology interests.

Best Scientists Citing Filip De Keyser

Trending Scientists